Find out who we are.
About Us
Equine Integrated Health is a collaboration between likeminded, passionate health professionals to drive innovation within the equine industry for the betterment of horse health and welfare.
By utilising cutting edge research, we aim to help advance veterinary healthcare to proactively optimise health. Our goal is to provide an integrated, data-driven service dedicated to optimising equine health, welfare and performance.
Our initial research project is to determine what the healthy horse microbiome looks like. The goal of this research is to develop a service for usage by veterinarians, horse trainers and owners to proactively manage horse health, and pathology.
Dr. Stephanie Bond
Dr. Stephanie Bond is passionate about providing access to cutting edge research to those who will use it to provide better welfare for horses. A prolific researcher who has co-authored 23 papers in the equine veterinary space, Stephanie brings a rare combination of extensive academic experience as well as intimate practical knowledge of the equine industry. She obtained a Bachelor of Veterinary Science (Hons) and a Bachelor of Animal Science from the University of Melbourne in 2013, and received a PhD in Veterinary Medical Sciences from the University of Calgary in 2019. Dr. Bond was the first recipient of the Storm Cat Career Development Award (Grayson-Jockey Club Research Foundation) to be enrolled at a university outside of the USA.
Steph is our Founder and CEO
Ebonie MacLeod
Ebonie MacLeod is a commercially driven executive and lifelong horsewoman with over a decade of leadership experience at the forefront of equine health and veterinary pharmaceuticals. As Founder and CEO of Equinnovate, she introduced Australia’s first validated quantitative point-of-care diagnostic platform for Serum Amyloid A and Foal IgG, driving advancements in foal care and antimicrobial stewardship. Her work has forged key partnerships with government, global suppliers, and industry bodies—positioning Equinnovate as a rising force in veterinary innovation.
Alongside her role at Equinnovate, Ebonie has also led the early-stage development of veterinary therapeutics, leading the commercialisation pathway for novel intellectual property. In this capacity, she directed the creation of a patentable treatment, managed multidisciplinary global teams, and supported regulatory strategy and clinical trial design—bringing critical expertise to the foundational stages of innovation in equine health.
Previously, she played a key role in national product rollouts for AVet Health and Troy Animal Healthcare, delivering market growth through a strong alignment of clinical need, product design, and commercial strategy.
Ebonie’s career is underpinned by a passion for the horse industry that began as a child and has taken her through diverse roles in the racing and breeding sectors in both Australia and abroad. Today, she remains hands-on as a bloodstock consultant, racehorse owner, and licensed stablehand—ensuring her work stays connected to the real-world challenges faced by veterinarians, owners, and trainers alike.
She holds a Bachelor of Business and certifications in Equine Welfare and Drug Development from leading institutions. Ebonie combines strategic leadership, regulatory expertise, and deep equine market insight to deliver meaningful innovation and lasting impact across the veterinary and wider horse industry.